Medicinal prophylaxis of acute injury of the gastric mucosa: systematic review
DOI:
https://doi.org/10.33448/rsd-v12i4.41071Keywords:
Stomach Ulcer; Drug Therapy; Critical care; Anti-ulcer agents.Abstract
For critically ill patients, drug prophylaxis of acute gastric mucosal injury can be defined as the prevention or reduction in gastrointestinal bleeding rates by the use of drugs. The aim of this study was to gather scientific evidence on drug prophylaxis of acute gastric mucosal injury for the development of an institutional protocol for critically ill patients. This is a literature review based on the elaboration of a guiding question for the research, using the acronym PICO. The databases used to search for articles were PubMed, Lilacs and Cochrane, in addition to the gray literature. 98 articles were found, 78 in PubMed, 19 in Lilacs and 01 in Cochrane. After selection strategies, 13 studies were included, which were read in full for the construction of the protocol. Study bias was assessed according to the JADAD scale. It is possible to conclude that there is evidence supporting the use of drug prophylaxis for acute gastric mucosal injury in critically ill patients with known risk factors. Other measures can also help prevent stress ulcers, and their indication should be periodically reassessed.
References
Abjaude, S. A. R. (2015). Avaliação do uso profilático de omeprazol em pacientes internados no hospital estadual Américo Braziliense [Dissertação]. Universidade Estadual Paulista – Julio de Mesquita Filho. Araraquara.
Alhazzani, W., Guyatt, G., Marshall, J. C., Hall, R., Muscedere, J., Lauzier, F., ... & Cook, D. (2016). Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial. Annals of Saudi Medicine, 36(6), 427-433.
Barbateskovic, M., Marker, S., Granholm, A., Anthon, C. T., Krag, M., Jakobsen, J. C., ... & Møller, M. H. (2019). Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive care medicine, 45(2), 143-158.
Brasil. (2021). Agência Nacional de Vigilância Sanitária. Bulário Eletrônico. bula/index.asp. Disponível em: https://consultas.anvisa.gov.br/#/bulario/
Buckley, M. S., Park, A. S., Anderson, C. S., Barletta, J. F., Bikin, D. S., Gerkin, R. D., ... & Kane-Gill, S. L. (2015). Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. The American journal of medicine, 128(8), 905-913.
Buendgens, L., Koch, A., & Tacke, F. (2016). Prevention of stress-related ulcer bleeding at the intensive care unit: risks and benefits of stress ulcer prophylaxis. World J Crit Care Med., 5(1):57-64.
Cardoso, D. S., Matos, L. E. O., Barrros, I. M. da C., Lisboa, J. S., Fernandes, S. S. S., Lima, T. C. (2022). Development of a proton pump inhibitor protocol in the prophylaxis of acute gastric mucosal injury: experience report. Research, Society and Development, 11(8):e25211830865.
Cotta, L. S. F., Predebon, S. S., Didonet, J., Mascarenhas, M., & Jacobus, A. P. Uso racional de omeprazol. Infarma. 2011; 23 (9-12): 32.
El-Kersh, K., Jalil, B., McClave, S. A., Cavallazzi, R., Guardiola, J., Guilkey, K., ... & Saad, M. (2018). Enteral nutrition as stress ulcer prophylaxis in critically ill patients: a randomized controlled exploratory study. Journal of Critical Care, 43, 108-113.
Espindola, V. B., Cardoso, T. F. M., Sversut, R. A., Carollo, A. R. H., do Amaral, M. S., & Kassab, N. M. (2015). Avaliação e comparação da qualidade de medicamentos contendo cloridrato ranitidina. Rev. Bras. Farm, 96(2), 1248-1265.
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled clinical trials, 17(1), 1-12.
Krag, M., Marker, S., Perner, A., Wetterslev, J., Wise, M. P., Schefold, J. C., ... & Møller, M. H. (2018). Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. New England Journal of Medicine, 379(23), 2199-2208.
Krag, M., Perner, A., Wetterslev, J., & Møller, M. H. (2013). Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiologica Scandinavica, 57(7), 835-847.
Krag, M., Perner, A., Wetterslev, J., Wise, M. P., Borthwick, M., Bendel, S., ... & Møller, M. H. (2016). Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials, 17(1), 1-18.
Madsen, K. R., Lorentzen, K., Clausen, N., Oberg, E., Kirkegaard, P. R., Maymann-Holler, N., & Moller, M. H. (2014). Guideline for stress ulcer prophylaxis in the intensive care unit. Dan Med J, 61(3), C4811.
Mahmoudi, L., Mohammadi, R., & Niknam, R. (2019). Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice. Clinicoecon Outcomes Res., 11:111-116.
Marker, S., Krag, M., & Møller, M. H. (2017). What's new with stress ulcer prophylaxis in the ICU?. Intensive Care Med., (43):1132-1134.
Munari, L., Hart, D., & Morrone, F. B. (2004). Uso de omeprazol en el hospital universitario de Porto Alegre-RS (Brasil). Seguim Farmacoter, 2(4):235-243.
Salim, N., Rahman, M. N. A., & Wahab, D. A. (2019). A systematic literature review of internal capabilities for enhancing ecoinnovation performance of manufacturing firms. Journal of Cleaner Production, 209:1445-1460. DOI: https://doi.org/10.1016/j.jclepro.2018.11.105
Santos, Y. D. A. P. D., Younes-Ibrahim, M. S., Crozatti, L. L., Raglione, D., Cardozo Junior, L. C. M., Besen, B. A. M. P., ... & Mendes, P. V. (2020). Adherence to a stress ulcer prophylaxis protocol by critically ill patients: a prospective cohort study. Revista Brasileira de Terapia Intensiva, 32, 37-42.
Saxena, B., & Singh, S. (2017). Comparison of three acute stress models for simulating the pathophysiology of stress-related mucosal disease. Drug Discov Ther., 11(2):98-103.
Toews, I., George, A. T., Peter, J. V., Kirubakaran, R., Fontes, L. E. S., Ezekiel, J. P. B., Meerpohl, J. J. (2018). Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev. 6(6). 10.1002/14651858.CD008687.pub2
Ye, Z., Blaser, A. R., Lytvyn, L., Wang, Y., Guyatt, G. H., Mikita, J. S., ... & Siemieniuk, R. A. (2020). Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. Bmj, 368.
Wolfe, M. (2021). Proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders. UpToDate.
Zhou, X., Fang, H., Xu, J., Chen, P., Hu, X., Chen, B., ... & Xu, Z. (2019). Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults-a meta-analysis of randomized controlled trials with trial sequential analysis. BMC gastroenterology, 19(1), 1-14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Tamiles Daiane Borges Santana; Ana Mercia Silva Mascarenhas; Diana Silva Lopes; Nara Jacqueline Sousa dos Santos; Gisele da Silveira Lemos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
